Holen Sie sich die Stockscreener-App
49.64
5.19%
-2.72
Handel nachbörslich:
49.64
Schlusskurs vom Vortag:
$52.36
Offen:
$51.6
24-Stunden-Volumen:
754.83K
Relative Volume:
2.12
Marktkapitalisierung:
$1.81B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-91.00M
KGV:
-13.53
EPS:
-3.67
Netto-Cashflow:
$-74.38M
1W Leistung:
-7.56%
1M Leistung:
-11.64%
6M Leistung:
+1.02%
1J Leistung:
-20.27%
1-Tages-Spanne:
$48.05
$51.77
1-Wochen-Bereich:
$48.05
$53.61
52-Wochen-Spanne:
$25.60
$68.73
Disc Medicine Inc Stock (IRON) Company Profile
Firmenname
Disc Medicine Inc
Sektor
Branche
Telefon
(617) 674-9274
Adresse
321 ARSENAL STREET, SUITE 101, WATERTOWN
Vergleichen Sie IRON mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IRON
Disc Medicine Inc
|
49.64 | 1.81B | 0 | -91.00M | -74.38M | -3.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.82 | 131.41B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
634.23 | 72.26B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
591.87 | 36.10B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
270.02 | 35.03B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
272.17 | 28.24B | 3.81B | -644.79M | -669.77M | -6.24 |
Disc Medicine Inc Stock (IRON) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-27 | Eingeleitet | TD Cowen | Buy |
| 2024-11-05 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-11-04 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2024-10-23 | Eingeleitet | Jefferies | Buy |
| 2024-10-16 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-08-22 | Eingeleitet | Wells Fargo | Overweight |
| 2024-04-01 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2023-12-19 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-06-09 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2023-06-07 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-05-17 | Eingeleitet | Raymond James | Outperform |
| 2023-04-28 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-04-21 | Eingeleitet | Stifel | Buy |
| 2023-04-20 | Eingeleitet | Morgan Stanley | Overweight |
| 2023-03-23 | Eingeleitet | BMO Capital Markets | Outperform |
| 2023-02-28 | Eingeleitet | SVB Securities | Outperform |
Alle ansehen
Disc Medicine Inc Aktie (IRON) Neueste Nachrichten
Swiss National Bank Sells 2,600 Shares of Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
Disc medicine director Ashiya Mona sells shares worth $310,483 By Investing.com - Investing.com Canada
Orbimed advisors sells $310,483 in disc medicine stock By Investing.com - Investing.com Australia
Is Disc Medicine, Inc. (NASDAQ:IRON) the Best Small Cap Stock to Buy Before They Explode? - Insider Monkey
Orbimed advisors sells $310,483 in disc medicine stock - Investing.com India
Disc medicine director Ashiya Mona sells shares worth $310,483 - Investing.com India
10 Best Small-Cap Stocks to Buy Before They Explode - Insider Monkey
Raymond James Financial Inc. Purchases New Position in Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
With 65% ownership, Disc Medicine, Inc. (NASDAQ:IRON) boasts of strong institutional backing - Yahoo Finance
Disc Medicine, Inc. (NASDAQ:IRON) Shares Purchased by Charles Schwab Investment Management Inc. - Defense World
Ashiya Mona sells $2.83 million in Disc Medicine stock By Investing.com - Investing.com South Africa
OrbiMed Advisors sells $2.83 million in Disc Medicine stock By Investing.com - Investing.com Philippines
Orbimed Advisors LLC Reduces Stake in Disc Medicine Inc: Analyzi - GuruFocus
Ashiya Mona sells $2.83 million in Disc Medicine stock - Investing.com
OrbiMed Advisors sells $2.83 million in Disc Medicine stock - Investing.com
ORBIMED ADVISORS LLC Reduces Stake in Disc Medicine Inc - GuruFocus
Disc Medicine, Inc. (NASDAQ:IRON) Given Consensus Recommendation of “Buy” by Analysts - Defense World
Bank of New York Mellon Corp Buys 4,356 Shares of Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
Disc Medicine’s SWOT analysis: rare blood disorder biotech stock’s potential By Investing.com - Investing.com South Africa
Disc Medicine’s SWOT analysis: rare blood disorder biotech stock’s potential - Investing.com
Disc Medicine (NASDAQ:IRON) Given New $132.00 Price Target at Cantor Fitzgerald - Defense World
Arizona State Retirement System Has $300,000 Stake in Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
All You Need to Know About Disc Medicine, Inc. (IRON) Rating Upgrade to Buy - Yahoo Finance
Disc Medicine (IRON) to Release Quarterly Earnings on Thursday - Defense World
Disc medicine director Ashiya Mona sells $16.97 million in stock By Investing.com - Investing.com South Africa
Orbimed advisors sells $16.97 million in disc medicine shares By Investing.com - Investing.com Australia
Disc Medicine’s SWOT analysis: stock poised for growth amid clinical milestones By Investing.com - Investing.com South Africa
Disc medicine director Ashiya Mona sells $16.97 million in stock - Investing.com India
Disc Medicine’s SWOT analysis: stock poised for growth amid clinical milestones - Investing.com India
Orbimed advisors sells $16.97 million in disc medicine shares - Investing.com India
Disc Medicine’s (IRON) Overweight Rating Reiterated at Morgan Stanley - Defense World
Certain Stock Options of Disc Medicine, Inc. are subject to a Lock-Up Agreement Ending on 9-MAR-2025. - Marketscreener.com
FY2025 EPS Forecast for Disc Medicine Increased by Analyst - Defense World
Disc Medicine (NASDAQ:IRON) Given New $75.00 Price Target at Scotiabank - MarketBeat
New York State Common Retirement Fund Cuts Stake in Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
Rhumbline Advisers Purchases 1,553 Shares of Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
Disc Medicine (NASDAQ:IRON) Price Target Raised to $75.00 at Scotiabank - Defense World
Wall Street Analysts Predict a 68.78% Upside in Disc Medicine, Inc. (IRON): Here's What You Should Know - Yahoo Finance
Disc Medicine price target raised to $75 from $73 at Scotiabank - TipRanks
Leerink Partnrs Comments on Disc Medicine Q1 Earnings - Defense World
Decoding Disc Medicine Inc (IRON): A Strategic SWOT Insight - GuruFocus.com
Disc Medicine (NASDAQ:IRON) Issues Quarterly Earnings Results, Beats Estimates By $0.08 EPS - MarketBeat
Finanzdaten der Disc Medicine Inc-Aktie (IRON)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.05%
1.79%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):